Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 19Unknown 11Recruiting 7Terminated 3Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Motor Activity 1Hyperthermia 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma 1

Interventions

Trastuzumab 77Capecitabine 59Cyclophosphamide 54Paclitaxel 51Docetaxel 49Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 25exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Everolimus 17Taxes 16Epirubicin 15Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13pertuzumab 12palbociclib 12liposomal doxorubicin 11Magnetic Resonance Spectroscopy 11Filgrastim 11Cisplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Control Groups × Clear all
NCT04385433 2023-08-24

PRAVAPREV-01

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Terminated
15 enrolled
Breast

Breast Neoplasms

NCT02433067 2020-10-06

CARDAPAC

University of Franche-Comté

Phase NA Terminated
89 enrolled
Breast

Breast Neoplasms

NCT00610467 2020-04-20

Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis

University of California, Irvine

Phase NA Terminated
2 enrolled 4 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡